Andrew Hill Investment Advisors Highlights Q4 2025 Portfolio Moves: Double-Digit Gains, New Positions, and Strategic Portfolio Adjustments

Andrew Hill Investment Advisors reported a third consecutive year of double-digit gains in 2025, with gold investments outperforming the broader market. The firm expanded its portfolio by adding positions in financial and healthcare sectors, including First Horizon (FHN) and Thermo Fisher Scientific (TMO). Costco (COST) was sold for tax loss purposes. The company's performance was driven by steady revenue growth, strong profitability, and conservative leverage.